
The first patients have completed 12-month follow-up in AlloSource’s five-year study, A Prospective, Multi-Center Study Evaluating ProChondrix® CR for the Repair of Focal Articular Cartilage Defects in the Knee.
ProChondrix CR cryopreserved osteochondral allograft is a single-stage option to deliver the components for articular cartilage restoration. This cartilage restoration therapy provides live, functional cells and biological components necessary for the repair and regeneration of damaged cartilage tissue. A two-year shelf life helps alleviate inventory management challenges of other cartilage products, and provides surgeons with more flexibility for their patients.
The first patients have completed 12-month follow-up in AlloSource's five-year study, A Prospective, Multi-Center Study Evaluating ProChondrix® CR for the Repair of Focal Articular Cartilage Defects in the Knee.
ProChondrix CR cryopreserved osteochondral allograft is a single-stage option to deliver the components for articular cartilage...
The first patients have completed 12-month follow-up in AlloSource’s five-year study, A Prospective, Multi-Center Study Evaluating ProChondrix® CR for the Repair of Focal Articular Cartilage Defects in the Knee.
ProChondrix CR cryopreserved osteochondral allograft is a single-stage option to deliver the components for articular cartilage restoration. This cartilage restoration therapy provides live, functional cells and biological components necessary for the repair and regeneration of damaged cartilage tissue. A two-year shelf life helps alleviate inventory management challenges of other cartilage products, and provides surgeons with more flexibility for their patients.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.